(Q50954965)
Statements
Combination of a bispecific antibody and costimulatory antibody-ligand fusion proteins for targeted cancer immunotherapy. (English)
1 reference
Nora Hornig
1 reference
Vanessa Kermer
1 reference
Katharina Frey
1 reference
Philipp Diebolder
1 reference
Roland E Kontermann
1 reference
Dafne Müller
1 reference
1 June 2012
1 reference
35
1 reference
5
1 reference
418-429
1 reference